Crestline Management, L.P. Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001536054

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedHealth TiltHigh Turnover how tags are computed

Q1 2025 · 3 positions · Total reported value $63.24M · Top-10 concentration 100.0% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 33.3% · 0 new · 1 cut · 0 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

In its Q1 2025 13F filing, Crestline Management, L.P. disclosed 3 equity positions with a combined reported value of $63.24M. The filing implies a focused portfolio: its ten largest positions account for 100.0% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q1 2025 were DNLI ($56.57M), SANA ($4.69M), EGHT ($1.98M). By sector, the heaviest allocations are Health Care 96.9%, Technology 3.1%. Versus the prior quarter, allocation shifted toward Health Care (+86.1pp) and away from Real Estate (-3.8pp), Utilities (-4.6pp).

Versus the prior quarter, Crestline Management, L.P. opened 0 new positions, trimmed 1 and fully exited 0, a turnover rate of 33.3% of positions. The portfolio's overlap with the prior quarter was 0% of names.

Of the 8 positions fully exited versus the prior quarter, the largest were IVV ($376.76M), NVDA ($94.42M), QQQ ($76.68M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q1 2025)

No new positions this quarter.

Fully Exited (vs previous quarter)

  • IVV ISHARES TR · prev qtr: $376.76M
  • NVDA NVIDIA CORPORATION · prev qtr: $94.42M
  • QQQ INVESCO QQQ TR · prev qtr: $76.68M
  • SPY STATE STR SPDR S&P 500 ETF T · prev qtr: $60.95M
  • AMZN AMAZON COM INC · prev qtr: $54.24M
  • GOOGL ALPHABET INC CL-A · prev qtr: $44.12M
  • JNJ JOHNSON & JOHNSON · prev qtr: $34.51M
  • CSCO CISCO SYS INC · prev qtr: $30.75M

Insider Transactions (Form 4)

Latest Crestline Management, L.P. buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Crestline Management, L.P., based in Fort Worth, TX, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 3 positions worth $53.48M in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: FORT WORTH, TX, United States
  • SEC registration: 801-61607 (status: Approved), registered 2002-12-02
  • Regulatory AUM (Form ADV): $22.51B as of 2026-08-28
  • Client mix (by RAUM): pension and profit-sharing plans 94%, sovereign wealth funds 5%
  • Manages 37 private funds, of which 30 hedge funds
  • Website: crestlineinvestors.com

Portfolio Structure

  • 3 positions · $53.48M reported value (Q2 2026)
  • Top 10 holdings = 100.0% of reported value
  • Largest position: DNLI (DENALI THERAPEUTICS INC) at 91.9%
  • Average position size: $17.83M

Sector Tilt

  • Health Care 96.8%
  • Information Technology 3.2%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 1 reduced
  • 2 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 96.9%
Technology 3.1%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 4.16M $56.57M 89.45%
89.45%
Reduce
2 2.79M $4.69M 7.42%
7.42%
Reduce
3 990.58K $1.98M 3.13%
3.13%
Reduce

FAQ

What did Crestline Management, L.P. buy in 2025-Q1?

In its 2025-Q1 13F filing, Crestline Management, L.P. reported 3 equity positions worth $63.24M in aggregate; its largest disclosed positions were DNLI ($56.57M), SANA ($4.69M), EGHT ($1.98M).

How large is Crestline Management, L.P.'s portfolio?

Crestline Management, L.P. reported $63.24M of long equity holdings across 3 positions as of 2025-Q1. Top-10 holdings account for 100.0% of reported value.

What is Crestline Management, L.P.'s investment style?

HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/crestline-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →